IRIS: A platform to assess, detect and respond to vulnerabilities and threats in ICT networks
March 18, 2022
Predictive eBoost’s project aims to improve the performance of electric vehicles’ powertrain and batteries
April 21, 2022The project Biomedical photonics and machine learning for the diagnosis and treatment of ocular disorders, cognitive deterioration and haematological diseases (BIOPHOCH), led by the Centre for Sensors, Instruments and Systems Development (CD6), is designed to develop new tools and methodologies for image analysis and processing of data in the health area using photonic techniques.
Biomedical photonics is leading to revolutionary discoveries in the health sector, where light-based instruments are already used for non-invasive diagnoses and treatments of patients. These advances are accompanied by the generation of a large quantity of data. It is in this area that BIOPHOCH has the mission of obtaining efficient algorithms that could process the information that is gathered.
What are the challenges of the BIOPHOCH project?
The project uses eye-tracking technology, spectral and confocal microscopy, among others, along with data analysis and machine learning algorithms to research and address the challenges in three medical areas:
- The diagnosis of ocular disorders using new methods of refraction and evaluation of the eye fundus.
- The objective evaluation of cognitive state (Alzheimer’s and persistent COVID) from the analysis of ocular movements.
- The diagnosis of haematological diseases through spectral confocal microscopy.
Through machine learning, the aim is to offer the capacity to classify and identify data patterns, with similar reliability to that of experienced doctors.
Continuity project with a multidisciplinary team
BIOPHOCH brings together in one project a highly complementary team comprised of physicists, optical engineers, software engineers and optometrists from the CD6 and various hospitals, including the Institute of Ocular Microsurgery (IMO), Terrassa Health Consortium (CST) and Sant Joan de Déu Hospital (HSJD). It is also supported by companies in the medical sector.
As part of the State R+D+I Programme Oriented to the Challenges of Society of the Ministry of Science and Innovation, BIOPHOCH has a budget of 242,000 euros and lasts 3 years (September 2021 to August 2024).
Technology
Sector
You want to know more?
Related Projects
- A research team from the UPC, in collaboration with the company B. Braun Surgical, has created a ceramic and biocompatible catalyst that captures greenhouse gases and transforms them into useful chemical products in a more sustainable way and at a lower cost than current technologies. The technology has successfully passed the pilot phase through joint projects with companies from different sectors.
- The Visualisation, Virtual Reality and Graphic Interaction Research Group (ViRVIG) at the Universitat Politècnica de Catalunya - BarcelonaTech (UPC) participates in the CLIPE project under the MSCA-ITN call, which has developed technologies to provide virtual characters in immersive VR/AR environments with natural behaviour and interaction between virtual characters, making them more human and realistic, with potential applications in industry, video games, training and simulation.
- As part of the DigiPatICS project, eight ICS hospitals have optimised breast cancer diagnosis thanks to artificial intelligence (AI) algorithms that automate the analysis of tissue samples, enabling earlier and more accurate detection of the disease. The results and diagnoses are shared in real time across the eight centres, thereby forming the largest pathology network in Europe.
- The research groups in Biomaterials, Biomechanics and Tissue Engineering (BBT) and the Barcelona Research Center in Multiscale Science and Engineering (CCEM) at the Universitat Politècnica de Catalunya – BarcelonaTech (UPC) have developed biodegradable shape-memory stents for pediatric patients with aortic coarctation.
